402 related articles for article (PubMed ID: 14977366)
1. Regulation of cannabinoid CB1 receptors in the central nervous system by chronic cannabinoids.
Sim-Selley LJ
Crit Rev Neurobiol; 2003; 15(2):91-119. PubMed ID: 14977366
[TBL] [Abstract][Full Text] [Related]
2. β-arrestin2 regulates cannabinoid CB1 receptor signaling and adaptation in a central nervous system region-dependent manner.
Nguyen PT; Schmid CL; Raehal KM; Selley DE; Bohn LM; Sim-Selley LJ
Biol Psychiatry; 2012 Apr; 71(8):714-24. PubMed ID: 22264443
[TBL] [Abstract][Full Text] [Related]
3. Brain regional differences in CB1 receptor adaptation and regulation of transcription.
Lazenka MF; Selley DE; Sim-Selley LJ
Life Sci; 2013 Mar; 92(8-9):446-52. PubMed ID: 22940268
[TBL] [Abstract][Full Text] [Related]
4. Behavioral effects of cannabinoid agents in animals.
Chaperon F; Thiébot MH
Crit Rev Neurobiol; 1999; 13(3):243-81. PubMed ID: 10803637
[TBL] [Abstract][Full Text] [Related]
5. Differential regulation of behavioral tolerance to WIN55,212-2 by GASP1.
Martini L; Thompson D; Kharazia V; Whistler JL
Neuropsychopharmacology; 2010 May; 35(6):1363-73. PubMed ID: 20164830
[TBL] [Abstract][Full Text] [Related]
6. Sex, THC, and hormones: Effects on density and sensitivity of CB
Farquhar CE; Breivogel CS; Gamage TF; Gay EA; Thomas BF; Craft RM; Wiley JL
Drug Alcohol Depend; 2019 Jan; 194():20-27. PubMed ID: 30391834
[TBL] [Abstract][Full Text] [Related]
7. Mutation of putative GRK phosphorylation sites in the cannabinoid receptor 1 (CB1R) confers resistance to cannabinoid tolerance and hypersensitivity to cannabinoids in mice.
Morgan DJ; Davis BJ; Kearn CS; Marcus D; Cook AJ; Wager-Miller J; Straiker A; Myoga MH; Karduck J; Leishman E; Sim-Selley LJ; Czyzyk TA; Bradshaw HB; Selley DE; Mackie K
J Neurosci; 2014 Apr; 34(15):5152-63. PubMed ID: 24719095
[TBL] [Abstract][Full Text] [Related]
8. Prolonged recovery rate of CB1 receptor adaptation after cessation of long-term cannabinoid administration.
Sim-Selley LJ; Schechter NS; Rorrer WK; Dalton GD; Hernandez J; Martin BR; Selley DE
Mol Pharmacol; 2006 Sep; 70(3):986-96. PubMed ID: 16760363
[TBL] [Abstract][Full Text] [Related]
9. Effects of chronic exposure to delta9-tetrahydrocannabinol on cannabinoid receptor binding and mRNA levels in several rat brain regions.
Romero J; Garcia-Palomero E; Castro JG; Garcia-Gil L; Ramos JA; Fernandez-Ruiz JJ
Brain Res Mol Brain Res; 1997 Jun; 46(1-2):100-8. PubMed ID: 9191083
[TBL] [Abstract][Full Text] [Related]
10. Cannabinoid CB1 receptor-interacting proteins: novel targets for central nervous system drug discovery?
Smith TH; Sim-Selley LJ; Selley DE
Br J Pharmacol; 2010 Jun; 160(3):454-66. PubMed ID: 20590557
[TBL] [Abstract][Full Text] [Related]
11. A molecular basis of analgesic tolerance to cannabinoids.
Tappe-Theodor A; Agarwal N; Katona I; Rubino T; Martini L; Swiercz J; Mackie K; Monyer H; Parolaro D; Whistler J; Kuner T; Kuner R
J Neurosci; 2007 Apr; 27(15):4165-77. PubMed ID: 17428994
[TBL] [Abstract][Full Text] [Related]
12. Differential activation of G protein-mediated signaling by synthetic cannabinoid receptor agonists.
Sachdev S; Banister SD; Santiago M; Bladen C; Kassiou M; Connor M
Pharmacol Res Perspect; 2020 Apr; 8(2):e00566. PubMed ID: 32101383
[TBL] [Abstract][Full Text] [Related]
13. Molecular and Behavioral Pharmacological Characterization of Abused Synthetic Cannabinoids MMB- and MDMB-FUBINACA, MN-18, NNEI, CUMYL-PICA, and 5-Fluoro-CUMYL-PICA.
Gamage TF; Farquhar CE; Lefever TW; Marusich JA; Kevin RC; McGregor IS; Wiley JL; Thomas BF
J Pharmacol Exp Ther; 2018 May; 365(2):437-446. PubMed ID: 29549157
[TBL] [Abstract][Full Text] [Related]
14. Changes in the cannabinoid receptor binding, G protein coupling, and cyclic AMP cascade in the CNS of rats tolerant to and dependent on the synthetic cannabinoid compound CP55,940.
Rubino T; Viganò D; Massi P; Parolaro D
J Neurochem; 2000 Nov; 75(5):2080-6. PubMed ID: 11032897
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoid tolerance and dependence.
Lichtman AH; Martin BR
Handb Exp Pharmacol; 2005; (168):691-717. PubMed ID: 16596793
[TBL] [Abstract][Full Text] [Related]
16. Altered CB1 receptor and endocannabinoid levels precede motor symptom onset in a transgenic mouse model of Huntington's disease.
Dowie MJ; Bradshaw HB; Howard ML; Nicholson LF; Faull RL; Hannan AJ; Glass M
Neuroscience; 2009 Sep; 163(1):456-65. PubMed ID: 19524019
[TBL] [Abstract][Full Text] [Related]
17. The effects of cannabinoids on the brain.
Ameri A
Prog Neurobiol; 1999 Jul; 58(4):315-48. PubMed ID: 10368032
[TBL] [Abstract][Full Text] [Related]
18. Dysregulation of cannabinoid CB1 receptor and associated signaling networks in brains of cocaine addicts and cocaine-treated rodents.
Álvaro-Bartolomé M; García-Sevilla JA
Neuroscience; 2013 Sep; 247():294-308. PubMed ID: 23727505
[TBL] [Abstract][Full Text] [Related]
19. Repeated administration of phytocannabinoid Δ(9)-THC or synthetic cannabinoids JWH-018 and JWH-073 induces tolerance to hypothermia but not locomotor suppression in mice, and reduces CB1 receptor expression and function in a brain region-specific manner.
Tai S; Hyatt WS; Gu C; Franks LN; Vasiljevik T; Brents LK; Prather PL; Fantegrossi WE
Pharmacol Res; 2015 Dec; 102():22-32. PubMed ID: 26361728
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoid-induced tolerance is associated with a CB1 receptor G protein coupling switch that is prevented by ultra-low dose rimonabant.
Paquette JJ; Wang HY; Bakshi K; Olmstead MC
Behav Pharmacol; 2007 Dec; 18(8):767-76. PubMed ID: 17989514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
